Stock ACBM ACRO BIOMEDICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Acro Biomedical Co., Ltd.

Equities

ACBM

US0048921052

Food Processing

Market Closed - OTC Markets
Other stock markets
 18:16:30 15/11/2023 GMT 		5-day change 1st Jan Change
0.105 USD -.--% Intraday chart for Acro Biomedical Co., Ltd. -.--% -.--%
2023 Acro Biomedical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
2023 Acro Biomedical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022
Capitalization 1 183.9 173.8 138.5 279.2 270.2
Enterprise Value (EV) 1 184 173.9 138.8 279.2 270.3
P/E ratio 437 x -469 x -1,179 x -32.5 x -17 x
Yield - - - - -
Capitalization / Revenue 22.9 x 225 x 201 x 233 x 410 x
EV / Revenue 23 x 225 x 202 x 233 x 410 x
EV / EBITDA - - - - -
EV / FCF -341 x 373 x -780 x 87.6 x 46.6 x
FCF Yield -0.29% 0.27% -0.13% 1.14% 2.15%
Price to Book 148 x 218 x 202 x 434 x 556 x
Nbr of stocks (in thousands) 47,760 47,760 47,760 60,042 60,042
Reference price 2 3.850 3.640 2.900 4.650 4.500
Announcement Date 28/12/18 27/03/20 02/04/21 15/04/22 21/07/23
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 0.51 8.014 0.7741 0.688 1.198 0.6585
EBITDA - - - - - -
EBIT 1 -0.002248 0.5156 -0.3017 -0.1305 -7.694 -15.87
Operating Margin -0.44% 6.43% -38.98% -18.96% -642.47% -2,409.98%
Earnings before Tax (EBT) 1 -0.002248 0.5119 -0.3035 -0.1355 -7.698 -15.87
Net income 1 -0.002248 0.4197 -0.3035 -0.1175 -7.698 -15.87
Net margin -0.44% 5.24% -39.2% -17.07% -642.82% -2,410.24%
EPS 2 -0.000047 0.008805 -0.007762 -0.002459 -0.1430 -0.2643
Free Cash Flow 1 -0.5196 -0.5389 0.4659 -0.178 3.186 5.803
FCF margin -101.89% -6.72% 60.18% -25.87% 266.04% 881.19%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 16/01/18 28/12/18 27/03/20 02/04/21 15/04/22 21/07/23
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 - 0.14 0.07 0.25 - 0.1
Net Cash position 1 0 - - - 0.02 -
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -0.52 -0.54 0.47 -0.18 3.19 5.8
ROE (net income / shareholders' equity) -0.91% 47.9% -35% -15.8% -1,158% -2,809%
ROA (Net income/ Total Assets) -0.51% 31.7% -21.6% -8.45% -547% -1,369%
Assets 1 0.4407 1.323 1.403 1.39 1.408 1.159
Book Value Per Share 2 0.0100 0.0300 0.0200 0.0100 0.0100 0.0100
Cash Flow per Share 2 0 0 0 0 0 0
Capex - - - - - -
Capex / Sales - - - - - -
Announcement Date 16/01/18 28/12/18 27/03/20 02/04/21 15/04/22 21/07/23
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Special Foods & Wellbeing Products

1st Jan change Capi.
ACRO BIOMEDICAL CO., LTD. Stock Acro Biomedical Co., Ltd.
-.--% 6.3M
ZHEJIANG NHU COMPANY LTD. Stock Zhejiang NHU Company Ltd.
+19.40% 8.71B
BELLRING BRANDS, INC. Stock BellRing Brands, Inc.
+6.26% 7.81B
CSPC INNOVATION PHARMACEUTICAL CO., LTD. Stock CSPC Innovation Pharmaceutical Co., Ltd.
+7.42% 6.69B
THE SIMPLY GOOD FOODS COMPANY Stock The Simply Good Foods Company
-6.19% 3.78B
BYHEALTH CO., LTD Stock Byhealth Co., Ltd
-6.64% 3.77B
XIAMEN KINGDOMWAY GROUP COMPANY Stock Xiamen Kingdomway Group Company
-3.06% 1.41B
HERBALIFE LTD. Stock Herbalife Ltd.
-26.54% 1.13B
SIRIO PHARMA CO., LTD. Stock Sirio Pharma Co., Ltd.
+20.86% 1.07B
USANA HEALTH SCIENCES, INC. Stock USANA Health Sciences, Inc.
-10.58% 906M
Special Foods & Wellbeing Products
  1. Stock Market
  2. Equities
  3. ACBM Stock
  4. Financials Acro Biomedical Co., Ltd.